Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2006 Jul 27;114(10):1542–1546. doi: 10.1289/ehp.9337

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.

PMC Copyright notice

Effects of PND1–4 diazinon or parathion treatment on 5HT transporter binding (A). Abbreviations: bs, brainstem; fb, forebrain. Data are presented as the percentage change from control values (Table 1). ANOVA across all contributing variables indicates a significant treatment × region interaction (p < 0.02), with significant differences detected in both the brainstem (p < 0.02) and forebrain (p < 0.05). Accordingly, results were subdivided into brainstem (B) and forebrain (C), but combined for males and females because of the absence of a treatment × sex interaction.

*Significantly different from control.